Edvardas Satkauskas, Sentante - Remote Surgical Robot for Endovascular Interventions | LSI USA '24

Edvardas Satkauskas  0:04  
Morning at restaurants in time to really glad to be here today. We develop tele operated and vascular robot. So it all started back in 80s. Many things happened I was born and the first angioplasty is were performed. And a lot of things have changed since then. So we no longer use mechanical typewriters to draft press releases. We gone digital long time ago. 1000s of new endovascular devices have been developed since then. But the process to deliver endovascular treatment is still the same as it was 40 years ago. DR is standing next to a running X ray source and manually manipulates guidewires and catheters inserted into patient. Now we know that x ray causes DNA damage, cancer and cataracts for doctors and nurses. You can ignore that, but you cannot ignore back pain caused by lead aprons and orthopedic issues. And doctors and nurses face that every day and endovascular interventions, and our standard of care for most critical conditions. Millions of patients are treated every day for heart attack, stroke, peripheral artery disease and some types of cancer. Do doctors do a good job in treating those patients? Absolutely, if they skilled, just like a good secretary did a good job with mechanical typewriter. But we first of all, we don't have enough skilled doctors. And for emerging conditions like stroke, only 20% of patient actually received the treatment because they just don't get the hospital in time. So can we do better Can we go digital? Yes, but there are some must haves that the good robotic system should offer first of all, anti procedure has to be done, it has to be able to do the job. More than that better than if you can do different types of procedures. The system has to be easy to use, the system has to integrate into existing clinical workflow easily and integrate an existing infrastructure and of course it has to be teleoperated and protect physicians from X ray. Well, existing robots can do part of the procedure part of specific procedure. They are not easy to use. They use joysticks have no haptic force feedback, and they actually say Manos, so they mess up clinical workflow significantly. So we did not go digital as of yet. But let me introduce you this entire team is smart sensory tele operated and the vascular robot system, which for the first time ever allows entire endovascular intervention to be performed from agencies room from a control room and in the future from a different hospital. And it is not a robotic assisted procedure. It is a fully robotic intervention. Since it is compatible with most standard off the shelf and vascular devices. We are device agnostic. And it can manipulate three endovascular devices simultaneously, allowing entire procedure from very beginning to very end to be performed. Using using robot. We can use different devices we can perform different procedures manipulated from a remote cockpit. But that's the must have for endovascular robotics. The most most important thing is how we do that we developed a revolutionary user interface. The robot is controlled by guide wire catheter and guide catheter the set of three devices that physician normally would use for endovascular interventions. And whatever does whatever physician does, he pushes the guidewire robots replicates exact same movement in the patient side, you rotate the catheter, and the robot would replicate the same movement in the patient side. But if there's resistance in the vessel, the doctor has possibility to feel it has ability to feel it real time haptic force feedback creates the same sensation just as if the doctor would work manually next to a patient. But that's not enough. Santana is a digital robotic system. So we have robotic accuracy. And there is like number of robots out there just designed just for that. We have extreme precision and motion scaling the robots just for that robot can hold devices for you. There are separate category of robots that are doing doing just for that build just for that. And we have designed the robot that integrates all this functionality into one robot, which is fine too and find the vascular interventions. We did Animal tests with zero extra exposure to all medical personnel. Doctors just love the technology. We have recently completed cadaver tests with 100% of success rate, and we get those reactions from doctors they just love it. So since it is going to the market, and we are set to modernize more than 10,000 cath labs worldwide, that's 5 billion euro market just for the system along with each system installed in hospital with generate recurring revenue stream from procedure consumables. And since we are a digital system, we have flexibility to use multiple revenue models such as equipment lease model, such as pay per use model to drive market adoption. So as of today, we have developed our fourth prototype we achieved design freeze last year. We are preparing the system for first inhuman a few months. And next years Anton is going to market and will forever change how endovascular interventions are performed. We're going step by step. Our first indication is peripheral vascular to demonstrate the system capabilities we have really strong Kol traction and physician benefits, ideal setting to demonstrate system capabilities as the next step and even stronger value proposition for newer intervention. So we can help millions of stroke patients to have improved access of care and have better patient outcomes. And then we expand to coronaries where we have a lot of influential care Wells who want to get out of those LEDs really badly. We have a great management team experienced in med tech business creation and global business development. We have experience super Medical Advisory Board with really most prominent physicians joining us. We have great advisors who business advisors who lead commercial teams and commercialized different endovascular robots of a company that were acquired with over a billion dollar acquisitions. And we're just starting, we are building a digital platform for digital cath lab. So we're just in stage one, we are empowering physician with tele operated and vascular robot system. But very soon, we're going to be off offering a completely tailor intervention basically enter hospital tele interventions to help those stroke patients and allow hospitals to optimize the processes. But haptic force feedback that we have, it's not just a feature, it's the data. We paired this data with X ray imaging data and we have digital footprint of the entire procedure. So we'll use this data to optimize procedure procedures. We'll use this data to develop training models, we can use intent as very realistic training platform. And in the end, we'll use this data to train AI to increase autonomy of the of the robot. So that's the future of endovascular interventions. We will our proprietary technology from scratch, and really happy to talk with you if you want to be part of this. Thank you so much.